Dalia El-Gamal
@drdaliaelgamal
#CancerResearch #CancerTherapeutics #TMEinteractions #WomeninScience #UMMC Opinions are my own.
ID: 884824001037688832
11-07-2017 17:17:35
162 Tweet
175 Followers
406 Following
I think we need to talk about how devastating this cancer microbiome refutation paper from Steven Salzberg 💙💛 and colleagues is. It really speaks to how devoid of critical thinking and intellectual depth our glam publishing ecosystem has become. 1/n biorxiv.org/content/10.110…
Proud to share our latest preclinical work describing SpiD3 for B-cell malignancies #CLL Congratulations to Alexandria Eiken and the Team # ElGamal Lab # Natarajan Lab Research @ UNMC University of Nebraska Medical Center Buffett Cancer Center
Happy graduation day! 🎓 The Baxter Arena is filled with grads, family and friends!
Happy to share our work JCI insight on BET inhibition with #OPN51107 as a therapeutic strategy to reshape immunosuppressive leukemia TME & reprogram exhausted T cells epigenome University of Nebraska Medical Center UNMC Heme Onc. Congrats to Audrey Smith, our amazing team & collaborators doi.org/10.1172/jci.in…
Mounting #mpox infections and deaths have led World Health Organization (WHO) to once again declare a Public Health Emergency of International Concern (PHEIC). Today, an Editorial from The Lancet: “Mpox: the need for a coordinated international response” hubs.li/Q02LzxDC0
Happy to share our latest article “Targeted BET inhibition with OPN-51107 synergizes with venetoclax in CLL” Congratulations to the ElGamal Lab Fred & Pamela Buffett Cancer Center (Sydney Skupa and Alexandria Eiken) and the Hernandez-llizaliturri Lab Roswell Park tandfonline.com/doi/full/10.10…
Join me and co-guest editor Dr. Audrey Smith University of Nebraska Medical Center Fred & Pamela Buffett Cancer Center to contribute to our Special Issue “Innovative Approaches to Molecular Pathogenesis & Therapy of Lymphoid Malignancies” mdpi.com/si/221089 #mdpibiomedicines via Biomedicines MDPI Deadline: April 10th, 2025